{"id":77846,"date":"2023-08-30T17:55:09","date_gmt":"2023-08-30T21:55:09","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846"},"modified":"2023-08-30T17:55:09","modified_gmt":"2023-08-30T21:55:09","slug":"blood-test-for-parkinsons-disease-promising-in-early-study","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846","title":{"rendered":"Blood test for Parkinson&#8217;s disease promising in early study"},"content":{"rendered":"<div>\n<p><a href=\"https:\/\/www.foxnews.com\/health\/alzheimers-disease-may-detected-finger-prick-blood-test-earlier-diagnosis-treatment\" target=\"_blank\" rel=\"noopener\">An experimental blood test<\/a> that detected Parkinson\u2019s disease in a preliminary study could become the first specific tool for diagnosing the devastating neurodegenerative condition, researchers said on Wednesday.<\/p>\n<p>The test, which looks for cell damage associated with the disease, is years away from being commercially available. If its reliability is confirmed in future trials, the test would allow doctors to diagnose the condition earlier and start therapies sooner, before nervous system damage worsens, the researchers said.<\/p>\n<p>&#8220;Currently, Parkinson\u2019s disease is diagnosed largely based on symptoms, when patients already have significant neurological damage,&#8221; said study leader Laurie Sanders of Duke School of Medicine in Durham, North Carolina.<\/p>\n<p>The new <a href=\"https:\/\/www.foxnews.com\/health\/cancer-blood-test-dna-hope-earlier-detection-researchers\" target=\"_blank\" rel=\"noopener\">blood test measures DNA damage<\/a> in mitochondria, the structures inside cells that generate energy for cellular functions. Mitochondrial DNA damage is known to be associated with Parkinson&#8217;s disease.<\/p>\n<p>The test showed greater damage in blood cells from patients with Parkinson\u2019s compared to people without the disease, researchers reported in Science Translational Medicine.<\/p>\n<p><a href=\"https:\/\/www.foxnews.com\/lifestyle\/what-is-parkinsons-disease\" target=\"_blank\" rel=\"noopener\"><strong>WHAT IS PARKINSON&#8217;S DISEASE? SYMPTOMS, CAUSES, WAYS TO COPE WITH DIAGNOSIS<\/strong><\/a><\/p>\n<p>It also found elevated DNA damage in people with a genetic mutation called LRRK2 that increases the risk for Parkinson\u2019s disease, even in the absence of symptoms, they said.<\/p>\n<p>Presently, <a href=\"https:\/\/www.foxnews.com\/politics\/fda-declines-approval-amneal-pharmaceuticals-parkinsons-drug\" target=\"_blank\" rel=\"noopener\">drugs for Parkinson\u2019s disease<\/a> only help control symptoms. Sanders said she hopes that along with diagnosing Parkinson\u2019s, the new test will help identify drugs that can reverse or halt mitochondrial DNA damage and the disease process, as well as patients who could benefit from those drugs.<\/p>\n<p>Several companies including Abcam and Biogen with partner Denali Therapeutics are testing such experimental treatments.<\/p>\n<p>&#8220;A new blood-based diagnostic test would be a major advancement for Parkinson\u2019s disease, which afflicts 10 million people worldwide and is the second most common neurodegenerative disease after Alzheimer&#8217;s,&#8221; the researchers said.<\/p>\n<p>Going forward, the researchers plan to test the diagnostic in samples from high-risk individuals who have not yet developed symptoms.<\/p>\n<\/div>\n<p><a href=\"https:\/\/www.foxnews.com\/us\/blood-test-parkinsons-disease-promising-early-study\">Source &#8211; https:\/\/www.foxnews.com\/us\/blood-test-parkinsons-disease-promising-early-study <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>An experimental blood test that detected Parkinson\u2019s disease in a preliminary study could become the first specific tool for diagnosing the devastating neurodegenerative condition, researchers [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[16563],"tags":[],"stock_ticker":[],"class_list":["post-77846","post","type-post","status-publish","format-standard","hentry","category-market-news","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Blood test for Parkinson&#039;s disease promising in early study - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Blood test for Parkinson&#039;s disease promising in early study - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"An experimental blood test that detected Parkinson\u2019s disease in a preliminary study could become the first specific tool for diagnosing the devastating neurodegenerative condition, researchers [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-30T21:55:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/06\/businessman-showing-business-evolution1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"715\" \/>\n\t<meta property=\"og:image:height\" content=\"423\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/6e00efa2abc413bdc0bca51a90c54d36\"},\"headline\":\"Blood test for Parkinson&#8217;s disease promising in early study\",\"datePublished\":\"2023-08-30T21:55:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846\"},\"wordCount\":337,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"articleSection\":[\"Market News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846\",\"name\":\"Blood test for Parkinson's disease promising in early study - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"datePublished\":\"2023-08-30T21:55:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Blood test for Parkinson&#8217;s disease promising in early study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/6e00efa2abc413bdc0bca51a90c54d36\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/09\/360_F_336393115_5gCUfwn76x3MJaCJMYDKLoRebkC8QyrL-300x300.jpg\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/09\/360_F_336393115_5gCUfwn76x3MJaCJMYDKLoRebkC8QyrL-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/09\/360_F_336393115_5gCUfwn76x3MJaCJMYDKLoRebkC8QyrL-300x300.jpg\",\"caption\":\"admin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Blood test for Parkinson's disease promising in early study - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846","og_locale":"en_US","og_type":"article","og_title":"Blood test for Parkinson's disease promising in early study - Wall Street PR","og_description":"An experimental blood test that detected Parkinson\u2019s disease in a preliminary study could become the first specific tool for diagnosing the devastating neurodegenerative condition, researchers [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2023-08-30T21:55:09+00:00","og_image":[{"width":715,"height":423,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2021\/06\/businessman-showing-business-evolution1.jpg","type":"image\/jpeg"}],"author":"admin","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846"},"author":{"name":"admin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/6e00efa2abc413bdc0bca51a90c54d36"},"headline":"Blood test for Parkinson&#8217;s disease promising in early study","datePublished":"2023-08-30T21:55:09+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846"},"wordCount":337,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"articleSection":["Market News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846","url":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846","name":"Blood test for Parkinson's disease promising in early study - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"datePublished":"2023-08-30T21:55:09+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/blood-test-for-parkinsons-disease-promising-in-early-study-77846#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Blood test for Parkinson&#8217;s disease promising in early study"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/6e00efa2abc413bdc0bca51a90c54d36","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/09\/360_F_336393115_5gCUfwn76x3MJaCJMYDKLoRebkC8QyrL-300x300.jpg","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/09\/360_F_336393115_5gCUfwn76x3MJaCJMYDKLoRebkC8QyrL-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2022\/09\/360_F_336393115_5gCUfwn76x3MJaCJMYDKLoRebkC8QyrL-300x300.jpg","caption":"admin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/admin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/77846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=77846"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/77846\/revisions"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=77846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=77846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=77846"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=77846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}